Pindolol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Pindolol.
Product ID | 62559-560_8f109f01-0a6a-403b-b41c-14d782b6a7f6 |
NDC | 62559-560 |
Product Type | Human Prescription Drug |
Proprietary Name | Pindolol |
Generic Name | Pindolol |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-05-08 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA073609 |
Labeler Name | ANI Pharmaceuticals, Inc. |
Substance Name | PINDOLOL |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-05-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA073609 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-05-08 |
Ingredient | Strength |
---|---|
PINDOLOL | 5 mg/1 |
SPL SET ID: | 611be921-e9b6-4800-80b2-c2d4f677cdb2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-0052 | Pindolol | pindolol |
0378-0127 | Pindolol | pindolol |
10135-743 | Pindolol | Pindolol |
10135-744 | Pindolol | Pindolol |
29033-028 | Pindolol | Pindolol |
29033-029 | Pindolol | Pindolol |
57664-655 | Pindolol | Pindolol |
57664-656 | Pindolol | Pindolol |
62559-560 | Pindolol | Pindolol |
62559-561 | Pindolol | Pindolol |
68151-1320 | Pindolol | pindolol |
68151-3005 | Pindolol | pindolol |
70710-1063 | Pindolol | Pindolol |
70710-1064 | Pindolol | Pindolol |
70771-1134 | Pindolol | Pindolol |
70771-1135 | Pindolol | Pindolol |
72789-099 | Pindolol | pindolol |
72789-100 | Pindolol | pindolol |
72789-293 | Pindolol | Pindolol |
72789-294 | Pindolol | Pindolol |
76385-131 | Pindolol | pindolol |
76385-132 | Pindolol | pindolol |